PHARMDEKO Stock Overview
Engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Pharma Deko Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦1.83 |
| 52 Week High | ₦0 |
| 52 Week Low | ₦0 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | -16.82% |
| 5 Year Change | 22.00% |
| Change since IPO | -37.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHARMDEKO | NG Beverage | NG Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | 2.5% |
| 1Y | 0% | 12.9% | 51.2% |
Return vs Industry: PHARMDEKO underperformed the NG Beverage industry which returned 12.9% over the past year.
Return vs Market: PHARMDEKO underperformed the NG Market which returned 51.2% over the past year.
Price Volatility
| PHARMDEKO volatility | |
|---|---|
| PHARMDEKO Average Weekly Movement | 0% |
| Beverage Industry Average Movement | 6.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in NG Market | 8.5% |
| 10% least volatile stocks in NG Market | 3.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine PHARMDEKO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Isola Olukayode | www.pharmadekoplc.com |
Pharma Deko Plc engages in manufacturing, packaging, and marketing pharmaceutical and consumer products in Nigeria. It operates through three segments: Pharma, Consumer, and Contract. The company offers pharmaceutical products, such as Vitacee syrups and drops, Pharmadec syrups and drops, Brett mouthwash, Hexedene oral care medication, Parkalin range of cough syrup, Parkaling Pediatrics, Revitone Blood Tonic, Salins Liniment, Antasil tablets, Omepraz capsules, and Parkaprim tablets and suspension; and Sparxin, Pidiclox dry powder and capsules, and Amycin dry powder and capsules, as well as paracetamol under the Phardol Drops brand.
Pharma Deko Plc Fundamentals Summary
| PHARMDEKO fundamental statistics | |
|---|---|
| Market cap | ₦396.98m |
| Earnings (TTM) | -₦141.61m |
| Revenue (TTM) | ₦469.58m |
0.0x
P/S Ratio0.0x
P/E RatioIs PHARMDEKO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHARMDEKO income statement (TTM) | |
|---|---|
| Revenue | ₦469.58m |
| Cost of Revenue | ₦435.21m |
| Gross Profit | ₦34.37m |
| Other Expenses | ₦175.98m |
| Earnings | -₦141.61m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PHARMDEKO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:48 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pharma Deko Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|